Intervention Update

Injectable Prevention and Preventable Confusion: An advocate's guide to the prevention and therapeutic pipeline of antibodies, long-acting ARVs and vaccines

2015 is going to bring lots of activity in early- and mid-phase research on a range of prevention and treatment strategies that have very different dosing schedules, mechanisms of action and potential public health impacts. The one thing these experimental interventions have in common is that they’re delivered by an injection or similar strategy.

Does this mean that there’s a unified category of “injectable prevention”—far from it. The similarities are superficial and the differences are key. As many of these trials are moving ahead in similar populations and regions, it is key for advocates to understand the distinctions between these various options.